Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jul 1, 2022	Jul 1, 2021
Revenue	184.18	176.64	374.48	484.68	782.24
Revenue Growth (YoY)	4.27%	-52.83%	-22.74%	-38.04%	-9.68%
Cost of Revenue	163.15	156.79	277.92	337.75	469.3
Gross Profit	21.02	19.85	96.56	146.93	312.94
Selling, General & Admin	45.07	43.61	67.88	111.13	139.64
Other Operating Expenses	0.02	-	-	-	-
Operating Expenses	45.08	43.61	67.88	111.13	139.64
Operating Income	-24.06	-23.76	28.68	35.8	173.3
Interest Expense	-1.87	-4.4	-5.23	-4.88	-3.81
Other Non Operating Income (Expenses)	0.1	0.25	0.42	0.8	0.63
EBT Excluding Unusual Items	-25.83	-27.91	23.87	31.72	170.11
Gain (Loss) on Sale of Assets	-	-	0.7	-	-0.77
Pretax Income	-25.83	-27.91	24.57	31.72	169.34
Income Tax Expense	11	13.07	16.17	6.55	34.62
Net Income	-36.83	-40.98	8.41	25.17	134.73
Net Income to Common	-36.83	-40.98	8.41	25.17	134.73
Net Income Growth	-	-	-66.60%	-81.31%	-13.77%
Shares Outstanding (Basic)	116	116	116	116	114
Shares Outstanding (Diluted)	116	116	116	116	114
Shares Change (YoY)	-	-	-	2.17%	-
EPS (Basic)	-0.32	-0.35	0.07	0.22	1.18
EPS (Diluted)	-0.32	-0.35	0.07	0.22	1.18
EPS Growth	-	-	-66.60%	-81.71%	-13.77%
Free Cash Flow	57.89	23.64	42.92	47.6	-49.39
Free Cash Flow Per Share	0.50	0.20	0.37	0.41	-0.43
Dividend Per Share	0.015	0.010	-	0.100	0.400
Dividend Growth	50.00%	-	-	-75.00%	-
Gross Margin	11.42%	11.24%	25.79%	30.31%	40.01%
Operating Margin	-13.06%	-13.45%	7.66%	7.39%	22.15%
Profit Margin	-20.00%	-23.20%	2.25%	5.19%	17.22%
Free Cash Flow Margin	31.43%	13.38%	11.46%	9.82%	-6.31%
EBITDA	4.4	4.78	67.05	74.93	209.2
EBITDA Margin	2.39%	2.71%	17.90%	15.46%	26.74%
D&A For EBITDA	28.46	28.54	38.36	39.13	35.9
EBIT	-24.06	-23.76	28.68	35.8	173.3
EBIT Margin	-13.06%	-13.45%	7.66%	7.39%	22.15%
Effective Tax Rate	-	-	65.79%	20.64%	20.44%
Advertising Expenses	0.12	0.1	0.77	4.19	7.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.